Industry Research Reports

Home > Reports > Pharma & Healthcare > Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-02-25

Pages: 94 Pages

Report ld: 4291812

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Mucin 1 was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

North American market for Mucin 1 was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Mucin 1 was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Mucin 1 was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Mucin 1 include Akshaya Bio Inc, Bavarian Nordic A/S, Boehringer Ingelheim GmbH, Etubics Corp, GeoVax Labs Inc, Merck KGaA, Minerva Biotechnologies Corp, Transgene SA, Vaxil Bio Therapeutics Ltd, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Mucin 1, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mucin 1 by region & country, by Type, and by Application.

The Mucin 1 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mucin 1.

MARKET SEGMENTATION

By Company

Akshaya Bio Inc
Bavarian Nordic A/S
Boehringer Ingelheim GmbH
Etubics Corp
GeoVax Labs Inc
Merck KGaA
Minerva Biotechnologies Corp
Transgene SA
Vaxil Bio Therapeutics Ltd

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

TG-4010
GO-2032c
ImMucin
BI-1361849
Others

Segment by Application

Prostate Cancer
Breast Cancer
Colon Cancer
Ovarian Cancer
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Mucin 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Mucin 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Mucin 1 in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Mucin 1 Product Introduction

1.2 Global Mucin 1 Market Size Forecast

1.2.1 Global Mucin 1 Sales Value (2020-2031)

1.2.2 Global Mucin 1 Sales Volume (2020-2031)

1.2.3 Global Mucin 1 Sales Price (2020-2031)

1.3 Mucin 1 Market Trends & Drivers

1.3.1 Mucin 1 Industry Trends

1.3.2 Mucin 1 Market Drivers & Opportunity

1.3.3 Mucin 1 Market Challenges

1.3.4 Mucin 1 Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Mucin 1 Players Revenue Ranking (2024)

2.2 Global Mucin 1 Revenue by Company (2020-2025)

2.3 Global Mucin 1 Players Sales Volume Ranking (2024)

2.4 Global Mucin 1 Sales Volume by Company Players (2020-2025)

2.5 Global Mucin 1 Average Price by Company (2020-2025)

2.6 Key Manufacturers Mucin 1 Manufacturing Base and Headquarters

2.7 Key Manufacturers Mucin 1 Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Mucin 1

2.9 Mucin 1 Market Competitive Analysis

2.9.1 Mucin 1 Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Mucin 1 Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucin 1 as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 TG-4010

3.1.2 GO-2032c

3.1.3 ImMucin

3.1.4 BI-1361849

3.1.5 Others

3.2 Global Mucin 1 Sales Value by Type

3.2.1 Global Mucin 1 Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Mucin 1 Sales Value, by Type (2020-2031)

3.2.3 Global Mucin 1 Sales Value, by Type (%) (2020-2031)

3.3 Global Mucin 1 Sales Volume by Type

3.3.1 Global Mucin 1 Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Mucin 1 Sales Volume, by Type (2020-2031)

3.3.3 Global Mucin 1 Sales Volume, by Type (%) (2020-2031)

3.4 Global Mucin 1 Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Prostate Cancer

4.1.2 Breast Cancer

4.1.3 Colon Cancer

4.1.4 Ovarian Cancer

4.1.5 Others

4.2 Global Mucin 1 Sales Value by Application

4.2.1 Global Mucin 1 Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Mucin 1 Sales Value, by Application (2020-2031)

4.2.3 Global Mucin 1 Sales Value, by Application (%) (2020-2031)

4.3 Global Mucin 1 Sales Volume by Application

4.3.1 Global Mucin 1 Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Mucin 1 Sales Volume, by Application (2020-2031)

4.3.3 Global Mucin 1 Sales Volume, by Application (%) (2020-2031)

4.4 Global Mucin 1 Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Mucin 1 Sales Value by Region

5.1.1 Global Mucin 1 Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Mucin 1 Sales Value by Region (2020-2025)

5.1.3 Global Mucin 1 Sales Value by Region (2026-2031)

5.1.4 Global Mucin 1 Sales Value by Region (%), (2020-2031)

5.2 Global Mucin 1 Sales Volume by Region

5.2.1 Global Mucin 1 Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Mucin 1 Sales Volume by Region (2020-2025)

5.2.3 Global Mucin 1 Sales Volume by Region (2026-2031)

5.2.4 Global Mucin 1 Sales Volume by Region (%), (2020-2031)

5.3 Global Mucin 1 Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Mucin 1 Sales Value, 2020-2031

5.4.2 North America Mucin 1 Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Mucin 1 Sales Value, 2020-2031

5.5.2 Europe Mucin 1 Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Mucin 1 Sales Value, 2020-2031

5.6.2 Asia Pacific Mucin 1 Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Mucin 1 Sales Value, 2020-2031

5.7.2 South America Mucin 1 Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Mucin 1 Sales Value, 2020-2031

5.8.2 Middle East & Africa Mucin 1 Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Mucin 1 Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Mucin 1 Sales Value

6.2.1 Key Countries/Regions Mucin 1 Sales Value, 2020-2031

6.2.2 Key Countries/Regions Mucin 1 Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Mucin 1 Sales Value, 2020-2031

6.3.2 United States Mucin 1 Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Mucin 1 Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Mucin 1 Sales Value, 2020-2031

6.4.2 Europe Mucin 1 Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Mucin 1 Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Mucin 1 Sales Value, 2020-2031

6.5.2 China Mucin 1 Sales Value by Type (%), 2024 VS 2031

6.5.3 China Mucin 1 Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Mucin 1 Sales Value, 2020-2031

6.6.2 Japan Mucin 1 Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Mucin 1 Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Mucin 1 Sales Value, 2020-2031

6.7.2 South Korea Mucin 1 Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Mucin 1 Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Mucin 1 Sales Value, 2020-2031

6.8.2 Southeast Asia Mucin 1 Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Mucin 1 Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Mucin 1 Sales Value, 2020-2031

6.9.2 India Mucin 1 Sales Value by Type (%), 2024 VS 2031

6.9.3 India Mucin 1 Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Akshaya Bio Inc

7.1.1 Akshaya Bio Inc Company Information

7.1.2 Akshaya Bio Inc Introduction and Business Overview

7.1.3 Akshaya Bio Inc Mucin 1 Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Akshaya Bio Inc Mucin 1 Product Offerings

7.1.5 Akshaya Bio Inc Recent Development

7.2 Bavarian Nordic A/S

7.2.1 Bavarian Nordic A/S Company Information

7.2.2 Bavarian Nordic A/S Introduction and Business Overview

7.2.3 Bavarian Nordic A/S Mucin 1 Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Bavarian Nordic A/S Mucin 1 Product Offerings

7.2.5 Bavarian Nordic A/S Recent Development

7.3 Boehringer Ingelheim GmbH

7.3.1 Boehringer Ingelheim GmbH Company Information

7.3.2 Boehringer Ingelheim GmbH Introduction and Business Overview

7.3.3 Boehringer Ingelheim GmbH Mucin 1 Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Boehringer Ingelheim GmbH Mucin 1 Product Offerings

7.3.5 Boehringer Ingelheim GmbH Recent Development

7.4 Etubics Corp

7.4.1 Etubics Corp Company Information

7.4.2 Etubics Corp Introduction and Business Overview

7.4.3 Etubics Corp Mucin 1 Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 Etubics Corp Mucin 1 Product Offerings

7.4.5 Etubics Corp Recent Development

7.5 GeoVax Labs Inc

7.5.1 GeoVax Labs Inc Company Information

7.5.2 GeoVax Labs Inc Introduction and Business Overview

7.5.3 GeoVax Labs Inc Mucin 1 Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 GeoVax Labs Inc Mucin 1 Product Offerings

7.5.5 GeoVax Labs Inc Recent Development

7.6 Merck KGaA

7.6.1 Merck KGaA Company Information

7.6.2 Merck KGaA Introduction and Business Overview

7.6.3 Merck KGaA Mucin 1 Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Merck KGaA Mucin 1 Product Offerings

7.6.5 Merck KGaA Recent Development

7.7 Minerva Biotechnologies Corp

7.7.1 Minerva Biotechnologies Corp Company Information

7.7.2 Minerva Biotechnologies Corp Introduction and Business Overview

7.7.3 Minerva Biotechnologies Corp Mucin 1 Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Minerva Biotechnologies Corp Mucin 1 Product Offerings

7.7.5 Minerva Biotechnologies Corp Recent Development

7.8 Transgene SA

7.8.1 Transgene SA Company Information

7.8.2 Transgene SA Introduction and Business Overview

7.8.3 Transgene SA Mucin 1 Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Transgene SA Mucin 1 Product Offerings

7.8.5 Transgene SA Recent Development

7.9 Vaxil Bio Therapeutics Ltd

7.9.1 Vaxil Bio Therapeutics Ltd Company Information

7.9.2 Vaxil Bio Therapeutics Ltd Introduction and Business Overview

7.9.3 Vaxil Bio Therapeutics Ltd Mucin 1 Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 Vaxil Bio Therapeutics Ltd Mucin 1 Product Offerings

7.9.5 Vaxil Bio Therapeutics Ltd Recent Development

8 Industry Chain Analysis

8.1 Mucin 1 Industrial Chain

8.2 Mucin 1 Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Mucin 1 Sales Model

8.5.2 Sales Channel

8.5.3 Mucin 1 Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Mucin 1 Market Trends

Table 2. Mucin 1 Market Drivers & Opportunity

Table 3. Mucin 1 Market Challenges

Table 4. Mucin 1 Market Restraints

Table 5. Global Mucin 1 Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Mucin 1 Revenue Market Share by Company (2020-2025)

Table 7. Global Mucin 1 Sales Volume by Company (2020-2025) & (K Pcs)

Table 8. Global Mucin 1 Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Mucin 1 Price by Company (2020-2025) & (USD/Pcs)

Table 10. Key Manufacturers Mucin 1 Manufacturing Base and Headquarters

Table 11. Key Manufacturers Mucin 1 Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Mucin 1

Table 13. Global Mucin 1 Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mucin 1 as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Mucin 1 Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Mucin 1 Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Mucin 1 Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Mucin 1 Sales Market Share in Value by Type (2020-2025)

Table 20. Global Mucin 1 Sales Market Share in Value by Type (2026-2031)

Table 21. Global Mucin 1 Sales Volume by Type: 2020 VS 2024 VS 2031 (K Pcs)

Table 22. Global Mucin 1 Sales Volume by Type (2020-2025) & (K Pcs)

Table 23. Global Mucin 1 Sales Volume by Type (2026-2031) & (K Pcs)

Table 24. Global Mucin 1 Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Mucin 1 Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Mucin 1 Price by Type (2020-2025) & (USD/Pcs)

Table 27. Global Mucin 1 Price by Type (2026-2031) & (USD/Pcs)

Table 28. Global Mucin 1 Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Mucin 1 Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Mucin 1 Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Mucin 1 Sales Market Share in Value by Application (2020-2025)

Table 32. Global Mucin 1 Sales Market Share in Value by Application (2026-2031)

Table 33. Global Mucin 1 Sales Volume by Application: 2020 VS 2024 VS 2031 (K Pcs)

Table 34. Global Mucin 1 Sales Volume by Application (2020-2025) & (K Pcs)

Table 35. Global Mucin 1 Sales Volume by Application (2026-2031) & (K Pcs)

Table 36. Global Mucin 1 Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Mucin 1 Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Mucin 1 Price by Application (2020-2025) & (USD/Pcs)

Table 39. Global Mucin 1 Price by Application (2026-2031) & (USD/Pcs)

Table 40. Global Mucin 1 Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Mucin 1 Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Mucin 1 Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Mucin 1 Sales Value by Region (2020-2025) & (%)

Table 44. Global Mucin 1 Sales Value by Region (2026-2031) & (%)

Table 45. Global Mucin 1 Sales Volume by Region (K Pcs): 2020 VS 2024 VS 2031

Table 46. Global Mucin 1 Sales Volume by Region (2020-2025) & (K Pcs)

Table 47. Global Mucin 1 Sales Volume by Region (2026-2031) & (K Pcs)

Table 48. Global Mucin 1 Sales Volume by Region (2020-2025) & (%)

Table 49. Global Mucin 1 Sales Volume by Region (2026-2031) & (%)

Table 50. Global Mucin 1 Average Price by Region (2020-2025) & (USD/Pcs)

Table 51. Global Mucin 1 Average Price by Region (2026-2031) & (USD/Pcs)

Table 52. Key Countries/Regions Mucin 1 Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Mucin 1 Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Mucin 1 Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Mucin 1 Sales Volume, (2020-2025) & (K Pcs)

Table 56. Key Countries/Regions Mucin 1 Sales Volume, (2026-2031) & (K Pcs)

Table 57. Akshaya Bio Inc Company Information

Table 58. Akshaya Bio Inc Introduction and Business Overview

Table 59. Akshaya Bio Inc Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 60. Akshaya Bio Inc Mucin 1 Product Offerings

Table 61. Akshaya Bio Inc Recent Development

Table 62. Bavarian Nordic A/S Company Information

Table 63. Bavarian Nordic A/S Introduction and Business Overview

Table 64. Bavarian Nordic A/S Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 65. Bavarian Nordic A/S Mucin 1 Product Offerings

Table 66. Bavarian Nordic A/S Recent Development

Table 67. Boehringer Ingelheim GmbH Company Information

Table 68. Boehringer Ingelheim GmbH Introduction and Business Overview

Table 69. Boehringer Ingelheim GmbH Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 70. Boehringer Ingelheim GmbH Mucin 1 Product Offerings

Table 71. Boehringer Ingelheim GmbH Recent Development

Table 72. Etubics Corp Company Information

Table 73. Etubics Corp Introduction and Business Overview

Table 74. Etubics Corp Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 75. Etubics Corp Mucin 1 Product Offerings

Table 76. Etubics Corp Recent Development

Table 77. GeoVax Labs Inc Company Information

Table 78. GeoVax Labs Inc Introduction and Business Overview

Table 79. GeoVax Labs Inc Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 80. GeoVax Labs Inc Mucin 1 Product Offerings

Table 81. GeoVax Labs Inc Recent Development

Table 82. Merck KGaA Company Information

Table 83. Merck KGaA Introduction and Business Overview

Table 84. Merck KGaA Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 85. Merck KGaA Mucin 1 Product Offerings

Table 86. Merck KGaA Recent Development

Table 87. Minerva Biotechnologies Corp Company Information

Table 88. Minerva Biotechnologies Corp Introduction and Business Overview

Table 89. Minerva Biotechnologies Corp Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 90. Minerva Biotechnologies Corp Mucin 1 Product Offerings

Table 91. Minerva Biotechnologies Corp Recent Development

Table 92. Transgene SA Company Information

Table 93. Transgene SA Introduction and Business Overview

Table 94. Transgene SA Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 95. Transgene SA Mucin 1 Product Offerings

Table 96. Transgene SA Recent Development

Table 97. Vaxil Bio Therapeutics Ltd Company Information

Table 98. Vaxil Bio Therapeutics Ltd Introduction and Business Overview

Table 99. Vaxil Bio Therapeutics Ltd Mucin 1 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 100. Vaxil Bio Therapeutics Ltd Mucin 1 Product Offerings

Table 101. Vaxil Bio Therapeutics Ltd Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Mucin 1 Downstream Customers

Table 105. Mucin 1 Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Mucin 1 Product Picture

Figure 2. Global Mucin 1 Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Mucin 1 Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Mucin 1 Sales Volume (2020-2031) & (K Pcs)

Figure 5. Global Mucin 1 Sales Price (2020-2031) & (USD/Pcs)

Figure 6. Mucin 1 Report Years Considered

Figure 7. Global Mucin 1 Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Mucin 1 Players Sales Volume Ranking (2024) & (K Pcs)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Mucin 1 Revenue in 2024

Figure 10. Mucin 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. TG-4010 Picture

Figure 12. GO-2032c Picture

Figure 13. ImMucin Picture

Figure 14. BI-1361849 Picture

Figure 15. Others Picture

Figure 16. Global Mucin 1 Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 17. Global Mucin 1 Sales Value Market Share by Type, 2024 & 2031

Figure 18. Global Mucin 1 Sales Volume by Type (2020 VS 2024 VS 2031) & (K Pcs)

Figure 19. Global Mucin 1 Sales Volume Market Share by Type, 2024 & 2031

Figure 20. Global Mucin 1 Price by Type (2020-2031) & (USD/Pcs)

Figure 21. Product Picture of Prostate Cancer

Figure 22. Product Picture of Breast Cancer

Figure 23. Product Picture of Colon Cancer

Figure 24. Product Picture of Ovarian Cancer

Figure 25. Product Picture of Others

Figure 26. Global Mucin 1 Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 27. Global Mucin 1 Sales Value Market Share by Application, 2024 & 2031

Figure 28. Global Mucin 1 Sales Volume by Application (2020 VS 2024 VS 2031) & (K Pcs)

Figure 29. Global Mucin 1 Sales Volume Market Share by Application, 2024 & 2031

Figure 30. Global Mucin 1 Price by Application (2020-2031) & (USD/Pcs)

Figure 31. North America Mucin 1 Sales Value (2020-2031) & (US$ Million)

Figure 32. North America Mucin 1 Sales Value by Country (%), 2024 VS 2031

Figure 33. Europe Mucin 1 Sales Value, (2020-2031) & (US$ Million)

Figure 34. Europe Mucin 1 Sales Value by Country (%), 2024 VS 2031

Figure 35. Asia Pacific Mucin 1 Sales Value, (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Mucin 1 Sales Value by Region (%), 2024 VS 2031

Figure 37. South America Mucin 1 Sales Value, (2020-2031) & (US$ Million)

Figure 38. South America Mucin 1 Sales Value by Country (%), 2024 VS 2031

Figure 39. Middle East & Africa Mucin 1 Sales Value, (2020-2031) & (US$ Million)

Figure 40. Middle East & Africa Mucin 1 Sales Value by Country (%), 2024 VS 2031

Figure 41. Key Countries/Regions Mucin 1 Sales Value (%), (2020-2031)

Figure 42. Key Countries/Regions Mucin 1 Sales Volume (%), (2020-2031)

Figure 43. United States Mucin 1 Sales Value, (2020-2031) & (US$ Million)

Figure 44. United States Mucin 1 Sales Value by Type (%), 2024 VS 2031

Figure 45. United States Mucin 1 Sales Value by Application (%), 2024 VS 2031

Figure 46. Europe Mucin 1 Sales Value, (2020-2031) & (US$ Million)

Figure 47. Europe Mucin 1 Sales Value by Type (%), 2024 VS 2031

Figure 48. Europe Mucin 1 Sales Value by Application (%), 2024 VS 2031

Figure 49. China Mucin 1 Sales Value, (2020-2031) & (US$ Million)

Figure 50. China Mucin 1 Sales Value by Type (%), 2024 VS 2031

Figure 51. China Mucin 1 Sales Value by Application (%), 2024 VS 2031

Figure 52. Japan Mucin 1 Sales Value, (2020-2031) & (US$ Million)

Figure 53. Japan Mucin 1 Sales Value by Type (%), 2024 VS 2031

Figure 54. Japan Mucin 1 Sales Value by Application (%), 2024 VS 2031

Figure 55. South Korea Mucin 1 Sales Value, (2020-2031) & (US$ Million)

Figure 56. South Korea Mucin 1 Sales Value by Type (%), 2024 VS 2031

Figure 57. South Korea Mucin 1 Sales Value by Application (%), 2024 VS 2031

Figure 58. Southeast Asia Mucin 1 Sales Value, (2020-2031) & (US$ Million)

Figure 59. Southeast Asia Mucin 1 Sales Value by Type (%), 2024 VS 2031

Figure 60. Southeast Asia Mucin 1 Sales Value by Application (%), 2024 VS 2031

Figure 61. India Mucin 1 Sales Value, (2020-2031) & (US$ Million)

Figure 62. India Mucin 1 Sales Value by Type (%), 2024 VS 2031

Figure 63. India Mucin 1 Sales Value by Application (%), 2024 VS 2031

Figure 64. Mucin 1 Industrial Chain

Figure 65. Mucin 1 Manufacturing Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Mucin 1 market? zhanKai

The top companies in the global Mucin 1 market are Akshaya Bio Inc、Bavarian Nordic A/S、Boehringer Ingelheim GmbH.

Related Reports

Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mucin 1 was estimated to be worth US$ 300 million in 2025 and is projected to reach US$ 620 million, growing at a CAGR of 10.8% from 2026 to 2032.
Published Date: 2026-05-30
Pages: 193
USD 3950.00
(Single User License)
Global Mucin 1 Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mucin 1 market is projected to grow from US$ 300 million in 2025 to US$ 620 million by 2032, at a CAGR of 10.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-05-30
Pages: 240
USD 4900.00
(Single User License)
Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mucin 1 market size was US$ 300 million in 2025 and is forecast to reach a readjusted size of US$ 620 million by 2032 with a CAGR of 10.8% during the forecast period 2026-2032.
Published Date: 2026-05-30
Pages: 187
USD 4250.00
(Single User License)
Global Mucin 1 Market Research Report 2026
The global Mucin 1 market was valued at US$ 300 million in 2025 and is anticipated to reach US$ 620 million by 2032, at a CAGR of 10.8% from 2026 to 2032.
Published Date: 2026-05-30
Pages: 175
USD 2900.00
(Single User License)
Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mucin 1 market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 78
USD 4250.00
(Single User License)
Global Mucin 1 Market Research Report 2025
The global market for Mucin 1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 87
USD 2900.00
(Single User License)
Global Mucin 1 Market Insights, Forecast to 2030
The global Mucin 1 market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-26
Pages: 87
USD 4900.00
(Single User License)
Global Mucin 1 Market Research Report 2024
The global Mucin 1 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-08
Pages: 81
USD 2900.00
(Single User License)

Mucin 1- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mucin 1 was estimated to be worth US$ 300 million in 2025 and is projected to reach US$ 620 million, growing at a CAGR of 10.8% from 2026 to 2032.
Published: 2026-05-30
Pages: 193
USD 3950.00 (Single User License)
Global Mucin 1 Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mucin 1 market is projected to grow from US$ 300 million in 2025 to US$ 620 million by 2032, at a CAGR of 10.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-05-30
Pages: 240
USD 4900.00 (Single User License)
Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mucin 1 market size was US$ 300 million in 2025 and is forecast to reach a readjusted size of US$ 620 million by 2032 with a CAGR of 10.8% during the forecast period 2026-2032.
Published: 2026-05-30
Pages: 187
USD 4250.00 (Single User License)
Global Mucin 1 Market Research Report 2026
The global Mucin 1 market was valued at US$ 300 million in 2025 and is anticipated to reach US$ 620 million by 2032, at a CAGR of 10.8% from 2026 to 2032.
Published: 2026-05-30
Pages: 175
USD 2900.00 (Single User License)
Global Mucin 1 Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mucin 1 market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 78
USD 4250.00 (Single User License)
Global Mucin 1 Market Research Report 2025
The global market for Mucin 1 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 87
USD 2900.00 (Single User License)
Global Mucin 1 Market Insights, Forecast to 2030
The global Mucin 1 market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-26
Pages: 87
USD 4900.00 (Single User License)
Global Mucin 1 Market Research Report 2024
The global Mucin 1 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-08
Pages: 81
USD 2900.00 (Single User License)